by Randy E. Miller | Apr 24, 2024 | FDA, FOIA, News Media, SEC
FOIAengine: Insights From the Latest FDA and SEC Requests News media outlets are among the most prolific submitters of FOIA requests to federal agencies. These requests signal – in real time – the stories that journalists are researching and writing. To illustrate...
by Randy E. Miller | Mar 27, 2024 | FDA, FOIA, Hedge Funds, Law Firms, Litigation, Non-Profits, Pharmaceuticals, Politics, Short-Selling, Stock Market
FOIAengine: Conservative Activists, Law Firms, Non-Profits Signal Competing Agendas A review of the most recent Freedom of Information Act requests made to the Food and Drug Administration illustrates how political organizations, law firms, news media, and financial...
by Randy E. Miller | Feb 14, 2024 | FDA, FOIA, Hedge Funds, Litigation, Pharmaceuticals, Short-Selling, Stock Market
FOIAengine Breaks Down the Action Financial firms are continuing to monitor many of the pharmaceutical manufacturers we’ve reported on in recent months, including Krystal Biotech, Apellis Pharmaceuticals, Establishment Labs, Catalent and Astellas. That’s according to...
by Randy E. Miller | Jan 24, 2024 | FDA, FOIA, Law Firms, Litigation, Pharmaceuticals
In FOIAengine, a Law Firm’s Strategy Takes Shape When we tallied the hundreds of thousands of Freedom of Information Act requests filed with the federal government last year, one law firm stood out. According to PoliScio Analytics’ competitive-intelligence database...
by Randy E. Miller | Dec 13, 2023 | FDA, FOIA, Hedge Funds, Pharmaceuticals, Short-Selling, Stock Market
FOIAengine Reveals FOIA Requests About Establishment Labs Food and Drug Administration FOIA records released this month reveal that breast implant manufacturer Establishment Labs (NASDAQ: ESTA), previously targeted by well-known activist short-seller Hindenburg...
